{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:13:45Z","timestamp":1780708425899,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,21]],"date-time":"2008-12-21T00:00:00Z","timestamp":1229817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00108-008-2195-8","type":"journal-article","created":{"date-parts":[[2008,12,19]],"date-time":"2008-12-19T09:37:52Z","timestamp":1229679472000},"page":"17-26","source":"Crossref","is-referenced-by-count":4,"title":["Conn-Syndrom","Conn\u2019s syndrome"],"prefix":"10.1007","volume":"50","author":[{"given":"E.","family":"Born-Frontsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Quinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,21]]},"reference":[{"key":"2195_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/j.ajkd.2005.03.007","volume":"46","author":"Bianchi","year":"2005","unstructured":"Bianchi S, Bigazzi R, Campese VM (2005) Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. Am J Kidney Dis 46: 45\u201351","journal-title":"Am J Kidney Dis"},{"key":"2195_CR2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-130-9-199905040-00017","volume":"130","author":"Bornstein","year":"1999","unstructured":"Bornstein SR, Stratakis CA, Chrousos GP (1999) Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann Intern Med 130: 759\u2013771","journal-title":"Ann Intern Med"},{"key":"2195_CR3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/HYPERTENSIONAHA.106.086116","volume":"50","author":"Calhoun","year":"2007","unstructured":"Calhoun DA (2007) Is there an unrecognized epidemic of primary aldosteronism? Pro Hypertension 50: 447\u2013453","journal-title":"Pro Hypertension"},{"key":"2195_CR4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1378\/chest.125.1.112","volume":"125","author":"Calhoun","year":"2004","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Harding SM (2004) Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125: 112\u2013117","journal-title":"Chest"},{"key":"2195_CR5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E et al. (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168: 80\u201385","journal-title":"Arch Intern Med"},{"key":"2195_CR6","first-page":"3","volume":"45","author":"Conn","year":"1955","unstructured":"Conn JW (1955) Presidental address. I. Paintig background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45: 3\u201317","journal-title":"J Lab Clin Med"},{"key":"2195_CR7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/ndt\/gfk086","volume":"21","author":"Covic","year":"2006","unstructured":"Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2006) Is it time for spironolactone therapy in dialysis patients? Nephrol Dial Transplant 21: 854\u2013858","journal-title":"Nephrol Dial Transplant"},{"key":"2195_CR8","first-page":"16","volume":"Klin","author":"Diederich","year":"2007","unstructured":"Diederich S, Bidlingmaier M, Quinkler M, Reincke M (2007) Diagnosis of primary hyperaldosteronism. Med Klin (Munich) 102: 16\u201321","journal-title":"Med"},{"key":"2195_CR9","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C et al. (2008) Case detection, diagnosis and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 93: 3266\u20133281","journal-title":"J Clin Endocrinol Metab"},{"key":"2195_CR10","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199812173392507","volume":"339","author":"Ganguly","year":"1998","unstructured":"Ganguly A (1998) Current concepts - primary aldosteronism. N Engl J Med 339: 1828\u20131834","journal-title":"N Engl J Med"},{"key":"2195_CR11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.ju.0000162045.68387.c3","volume":"174","author":"Ishidoya","year":"2005","unstructured":"Ishidoya S, Ito A, Sakai K et al. (2005) Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol 174: 40\u201343","journal-title":"J Urol"},{"key":"2195_CR12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","volume":"60","author":"Jeunemaitre","year":"1987","unstructured":"Jeunemaitre X, Chatellier G, Kreft-Jais C et al. (1987) Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol 60: 820\u2013825","journal-title":"Am J Cardiol"},{"key":"2195_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","volume":"19","author":"Lim","year":"2001","unstructured":"Lim PO, Young WF, MacDonald TM (2001) A review of the medical treatment of primary aldosteronism. J Hypertens 19: 353\u2013361","journal-title":"J Hypertens"},{"key":"2195_CR14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF et al. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45: 1243\u20131248","journal-title":"J Am Coll Cardiol"},{"key":"2195_CR15","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/jc.2007-2055","volume":"93","author":"Mulatero","year":"2008","unstructured":"Mulatero P, Bertello C, Rossato D et al. (2008) Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab 93: 1366\u20131371","journal-title":"J Clin Endocrinol Metab"},{"key":"2195_CR16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC et al. (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89: 1045\u20131050","journal-title":"J Clin Endocrinol Metab"},{"key":"2195_CR17","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1210\/jc.2003-032179","volume":"89","author":"Olivieri","year":"2004","unstructured":"Olivieri O, Ciacciarelli A, Signorelli D et al. (2004) Aldosterone to renin ratio in a primary care setting: the bussolengo study. J Clin Endocrinol Metab 89: 4221\u20134226","journal-title":"J Clin Endocrinol Metab"},{"key":"2195_CR18","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","volume":"108","author":"Pitt","year":"2003","unstructured":"Pitt B, Reichek N, Willenbrock R et al. (2003) Effects of eplerenone, enalapril and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108: 1831\u20131838","journal-title":"Circulation"},{"key":"2195_CR19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F et al. (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348: 1309\u20131321","journal-title":"N Engl J Med"},{"key":"2195_CR20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 341: 709\u2013717","journal-title":"N Engl J Med"},{"key":"2195_CR21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.06-1442","volume":"131","author":"Pratt-Ubunama","year":"2007","unstructured":"Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL et al. (2007) Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 131: 453\u2013459","journal-title":"Chest"},{"key":"2195_CR22","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C et al. (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48: 2293\u20132300","journal-title":"J Am Coll Cardiol"},{"key":"2195_CR23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Desideri G et al. (2006) Renal damage in primary aldosteronism: results of the PAPY study. Hypertension 48: 232\u2013238","journal-title":"Hypertension"},{"key":"2195_CR24","first-page":"455","volume":"21","author":"Rossi","year":"2008","unstructured":"Rossi GP, Seccia TM, Pessina AC (2008) Primary aldosteronism: part II: subtype differentiation and treatment. J Nephrol 21: 455\u2013462","journal-title":"J Nephrol"},{"key":"2195_CR25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","volume":"19","author":"Rossi","year":"2008","unstructured":"Rossi GP, Sechi LA, Giacchetti G et al. (2008) Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 19: 88\u201390","journal-title":"Trends Endocrinol Metab"},{"key":"2195_CR26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjhyper.2004.06.029","volume":"18","author":"Sato","year":"2005","unstructured":"Sato A, Hayashi K, Saruta T (2005) Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease. Am J Hypertens 18: 44\u201349","journal-title":"Am J Hypertens"},{"key":"2195_CR27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","volume":"135","author":"Sawka","year":"2001","unstructured":"Sawka AM, Young WF, Thompson GB et al. (2001) Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 135: 258\u2013261","journal-title":"Ann Intern Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-008-2195-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2195-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:12:10Z","timestamp":1558584730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-008-2195-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,21]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["2195"],"URL":"https:\/\/doi.org\/10.1007\/s00108-008-2195-8","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,21]]}}}